260 related articles for article (PubMed ID: 18950559)
1. LDL reduction: how low should we go and is it safe?
Robinson JG
Curr Cardiol Rep; 2008 Nov; 10(6):481-7. PubMed ID: 18950559
[TBL] [Abstract][Full Text] [Related]
2. Role of colesevelam in combination lipid-lowering therapy.
Jones MR; Nwose OM
Am J Cardiovasc Drugs; 2013 Oct; 13(5):315-23. PubMed ID: 23913404
[TBL] [Abstract][Full Text] [Related]
3. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.
Reddy KJ; Singh M; Batsell RR; Bangit JR; Zaheer MS; John S; Varghese S; Molinella R
J Clin Hypertens (Greenwich); 2009 Dec; 11(12):766-8. PubMed ID: 20021539
[TBL] [Abstract][Full Text] [Related]
5. Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
Florentin M; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Curr Med Res Opin; 2008 Apr; 24(4):995-1009. PubMed ID: 18291066
[TBL] [Abstract][Full Text] [Related]
6. LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.
Phillips W; Schaefer S
Prev Cardiol; 2010; 13(2):69-71. PubMed ID: 20377808
[TBL] [Abstract][Full Text] [Related]
7. Colesevelam: a review of its use in hypercholesterolemia.
Robinson DM; Keating GM
Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
McKenney JM
Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy for dyslipidemia: safety and regulatory considerations.
Davidson MH
Am J Cardiol; 2002 Nov; 90(10B):50K-60K. PubMed ID: 12467940
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.
Gudzune KA; Monroe AK; Sharma R; Ranasinghe PD; Chelladurai Y; Robinson KA
Ann Intern Med; 2014 Apr; 160(7):468-76. PubMed ID: 24514899
[TBL] [Abstract][Full Text] [Related]
11. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for combined dyslipidemia.
Xydakis AM; Ballantyne CM
Am J Cardiol; 2002 Nov; 90(10B):21K-29K. PubMed ID: 12467937
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
14. Use of combination therapy for dyslipidemia: a lipid clinic approach.
Brown AS
Am J Cardiol; 2002 Nov; 90(10B):44K-49K. PubMed ID: 12467939
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.
Rivers SM; Kane MP; Busch RS; Bakst G; Hamilton RA
Endocr Pract; 2007; 13(1):11-6. PubMed ID: 17360295
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Davidson M
Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
[TBL] [Abstract][Full Text] [Related]
17. [Ezetimibe with statins].
Jublanc C; Giral P; Turpin G
Presse Med; 2006 Mar; 35(3 Pt 2):487-94. PubMed ID: 16550148
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein lowering therapy: an analysis of the options.
Sacks FM
J Am Coll Cardiol; 2002 Dec; 40(12):2135-8. PubMed ID: 12505225
[No Abstract] [Full Text] [Related]
20. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
Goumas GS
Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
